Nachrichten zur Alpine Immune Sciences Inc. Aktie

Could This Stock Be the Next Biotech Buyout?

Vertex Pharmaceuticals $4.9 billion purchase of Alpine Immune Sciences probably wont be the last acquisition of a company focused on…

Could This Stock Be the Next Biotech Buyout? @themotleyfool #stocks $VERA $VRTX $ALPN

Vertex Pharmaceuticals $4.9 billion purchase of Alpine Immune Sciences probably wont be the last acquisition of a company focused on…

Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex

Vertex (VRTX) is set to acquire Alpine Immune Sciences (ALPN) for $65 per share in cash. The transaction is likely…

What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences

…

Stocks making the biggest premarket moves: Nike, CarMax, Robinhood, Alpine Immune Sciences and more

These are the stocks posting the largest moves in the premarket.…

Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall By Investing.com

Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall…

Alpine Immune Sciences soars on $4.9bn Vertex takeover

Alpine Immune Sciences Inc shares continued higher in pre-market trading, after soaring on Wednesday following news of the firm’s US$4.9…

Vertex Pharmaceuticals: Übernahme von Alpine Immune Sciences - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Vertex Pharmaceuticals Inc.…

Milliarden-Deal! Ausgerechnet Vertex schlägt zu

Große Pharma- und Biotech-Unternehmen sind weiter auf der Suche nach aussichtsreichen Substanzen, um ihre Produktpipeline zu stärken. Der unangefochtene Weltmarktführer…

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion

…

After-hours movers: Alpine Immune Sciences, Costco, and more By Investing.com

After-hours movers: Alpine Immune Sciences, Costco, and more…

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion

With the acquisition, Vertex will add Alpines portfolio of protein-based immunotherapies to treat autoimmune and inflammatory diseases.…

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 bln

Vertex Pharmaceuticals will acquire therapy developer Alpine Immune Sciences for $65 per share, or about $4.9 billion in cash, the…

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion By Reuters

Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion…

Vertex enters into agreement to acquire Alpine Immune Sciences

…

Alpine Immune Sciences (ALPN) Moves 10.4% Higher: Will This Strength Last?

Alpine Immune Sciences (ALPN) saw its shares surge in the last session with trading volume being higher than average. The…

Oppenheimer lifts Alpine Immune Sciences stock target to $44 By Investing.com

Oppenheimer lifts Alpine Immune Sciences stock target to $44…

Alpine Immune Sciences, Inc. (ALPN) Q4 2023 Earnings Call Transcript

…

Alpine Immune Sciences, Inc. (ALPN) Q4 Earnings and Revenues Beat Estimates

Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of 146.88% and 346.89%, respectively, for the quarter ended December…

Ausblick: Alpine Immune Sciences gibt Ergebnis zum abgelaufenen Quartal bekannt

Alpine Immune Sciences wird am 18.03.2024 Zahlen zum jüngsten Quartal vorlegen, das am 31.12.2023 abgelaufen ist.Die Prognosen von 7 Analysten…

Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug

…

Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick By Investing.com

Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick…

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session - Adtran (NASDAQ:ADTN), Alpine Immune Sciences (NASDAQ:ALPN)

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase…

Alpine Immune Sciences down 1.9%, prices $150M offering

…

Alpine Immune Sciences: November 2023 Data Release Could Get Ball Rolling

…

Alpine Immune Sciences appoints Wolfgang Dummer as CMO

…

Warm Autoimmune Hemolytic Anemia Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight | Leading Companies - Zenas BioPharma, Sanofi, Johnson & Johnson, Novartis, Incyte, Rigel, Alpine Immune Sciences, Hutchison

The dynamics of the warm autoimmune hemolytic anemia market are anticipated to change in the coming years owing to the…